GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy

Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer deaths, primarily due to its high incidence of recurrence and metastasis. Considerable efforts have therefore been undertaken to develop effective therapies; however, effective anti-HCC therapies rely on identification of sui...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Bing, Zhang, Ruofei, Zhang, Jianlin, Hou, Yaxin, Chen, Xuehui, Zhou, Meng, Tian, Xiuyun, Hao, Chunyi, Fan, Kelong, Yan, Xiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531302/
https://www.ncbi.nlm.nih.gov/pubmed/31149036
http://dx.doi.org/10.7150/thno.30867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531302/
https://www.ncbi.nlm.nih.gov/pubmed/31149036
http://dx.doi.org/10.7150/thno.30867

Ejemplares similares